Inhibition of thyrotropin and prolactin secretion by dopamine in man
- PMID: 573767
- DOI: 10.1007/BF03346767
Inhibition of thyrotropin and prolactin secretion by dopamine in man
Abstract
The effect of dopamine on thyrotropin (TSH) and prolactin (PRL) levels was studied in 5 normal subjects, 7 women with galactorrhea, 9 acromegalics and 4 patients with primary hypothyroidism. Dopamine infused at the rate of 280 micrograms/min produced significant decrease in plasma TSH and PRL levels in all four groups, though a lower fall in TSH was noted in acromegalics. A similar reduction in PRL was also noted after 28 micrograms/min dopamine. Phentolamine infusion (0.5 mg/min) had no effect on PRL response to dopamine. These results indicate that a dopaminergic stimulation led to an inhibition of TSH and PRL secretion. Since the high polarity of dopamine impedes its passage through the blood-brain barrier, its site of action should be outside this barrier, probably in the pituitary.
Similar articles
-
Copulsatile release of thyrotropin and prolactin in normal and hypothyroid subjects.Thyroid. 1995 Oct;5(5):369-72. doi: 10.1089/thy.1995.5.369. Thyroid. 1995. PMID: 8563474
-
The influence of thyroid disorders on the dopaminergic regulation of prolactin, thyrotropin and growth hormone.J Endocrinol Invest. 1985 Oct;8(5):427-31. doi: 10.1007/BF03348530. J Endocrinol Invest. 1985. PMID: 3935709
-
Dissociated response of thyrotropin and prolactin to dopamine receptor blockade with domperidone in hypothyroid subjects.Horm Metab Res. 1991 Dec;23(12):605-8. doi: 10.1055/s-2007-1003765. Horm Metab Res. 1991. PMID: 1778595
-
[Diurnal rhythm of thyrotropin secretion in healthy women and in patients with primary hypothyroidism].Endokrynol Pol. 1983;34(1):35-44. Endokrynol Pol. 1983. PMID: 6347671 Review. Polish. No abstract available.
-
Dopamine-mimetic and antagonist drugs: diagnostic and therapeutic applications in endocrine disorders.Life Sci. 1981 Aug 31;29(9):867-83. doi: 10.1016/0024-3205(81)90388-x. Life Sci. 1981. PMID: 7029189 Review. No abstract available.
Cited by
-
Nomifensine decreases the thyroid-stimulating-hormone response to thyrotropin-releasing-hormone in normal subjects.J Endocrinol Invest. 1983 Apr;6(2):125-8. doi: 10.1007/BF03350584. J Endocrinol Invest. 1983. PMID: 6408155 Clinical Trial.
-
Hormonal profile in benign breast disease. Endocrine status of cyclical mastalgia patients.J Endocrinol Invest. 1988 Oct;11(9):679-83. doi: 10.1007/BF03350214. J Endocrinol Invest. 1988. PMID: 2975693
-
Some current aspects of clinical and experimental neuroendocrinology with particular reference to growth hormone, thyrotropin and prolactin.J Endocrinol Invest. 1979 Jul-Sep;2(3):307-31. doi: 10.1007/BF03350424. J Endocrinol Invest. 1979. PMID: 231066 Review. No abstract available.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources